Uptake of Recommended Vaccines During Pregnancy Among Publicly and Privately Insured People in the United States, December 2020–September 2022
American Journal of Public Health · 2025
DOI: 10.2105/ajph.2024.307899 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Public Health, 2025. Verfasst von Stacey L Rowe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stacey L. Rowe is with the School of Nursing and Health Professions, University of San Francisco, San Francisco, CA. Sheena G. Sullivan is with the S…. Hauptthemen laut MEDLINE: Insurance, Health, Influenza Vaccines, COVID-19 Vaccines, Pertussis Vaccine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NICHD NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Objectives
To estimate maternal COVID-19, influenza, and pertussis vaccine uptake during pregnancy by insurance type and identify factors characterizing those vaccinated and unvaccinated.
Methods
We conducted a US cohort study of pregnant individuals (for pregnancies ending December 11, 2020–September 30, 2022) using insurance claims data. We calculated vaccination probability using Kaplan-Meier methods and identified factors associated with vaccination through binomial regression with inverse probability weights.
Results
Among 695 887 pregnant individuals (median age = 32 years for privately and 27 years for publicly insured), the cumulative probability of COVID-19 vaccination was 43.0% (privately insured) and 11.8% (publicly insured). We observed marked disparities between influenza (33.2% vs 14.2%) and pertussis (70.3% vs 42.8%) vaccination. Only 6.8% (privately insured) and 1.1% (publicly insured) received all 3 vaccines. COVID-19 and influenza vaccination odds were lower among drug and tobacco users. People with high-risk medical conditions, particularly the publicly insured, commonly were vaccinated.
Conclusions
Marked vaccine uptake disparities exist between privately and publicly insured pregnant people. Understanding structural barriers, particularly for Medicaid enrollees, is critical to improving maternal vaccine access. ( Am J Public Health. 2025;115(3):354–363. https://doi.org/10.2105/AJPH.2024.307899 )
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stacey L. Rowe is with the School of Nursing and Health Professions, University of San Francisco, San Francisco, CA. Sheena G. Sullivan is with the School of Clinical Sciences, Monash University, Melbourne, Australia. F…
ORCID-Profile: Stacey L Rowe, Sheena G Sullivan, Matthew M Coates, Onyebuchi A Arah, Annette K Regan
Förderung
- NIAID NIH HHS
- NICHD NIH HHS
- NCI NIH HHS
Zitieren
APA
Rowe, S. L., Sullivan, S. G., Munoz, F. M., Coates, M. M., Arah, O. A., & Regan, A. K. (2025). Uptake of Recommended Vaccines During Pregnancy Among Publicly and Privately Insured People in the United States, December 2020–September 2022. American Journal of Public Health. https://doi.org/10.2105/ajph.2024.307899
Vancouver
Rowe SL, Sullivan SG, Munoz FM, Coates MM, Arah OA, Regan AK. Uptake of Recommended Vaccines During Pregnancy Among Publicly and Privately Insured People in the United States, December 2020–September 2022. American Journal of Public Health. 2025. doi:10.2105/ajph.2024.307899
BibTeX
@article{Rowe2025,
author = {Rowe, Stacey L and Sullivan, Sheena G and Munoz, Flor M and Coates, Matthew M and Arah, Onyebuchi A and Regan, Annette K},
title = {Uptake of Recommended Vaccines During Pregnancy Among Publicly and Privately Insured People in the United States, December 2020–September 2022},
journal = {American Journal of Public Health},
year = {2025},
doi = {10.2105/ajph.2024.307899}
}
EUVIMED